Position in PTGX
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$7,354
+$1,030 QoQ
Shares Held
60
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#305
of 341 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sankala Group LLC holds $1,316,200 across 16 Biotechnology names. PTGX ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
10,105 | $707,653 | |
| 2 | BNTX |
BioNTech SE
|
4,017 | $373,781 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
233 | $115,738 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64 | $39,906 | |
| 5 | CYTK |
Cytokinetics Inc
|
201 | $17,123 | |
| 6 | RPRX |
Royalty Pharma plc
|
197 | $11,045 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
186 | $10,812 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
This page
|
60 | $7,354 |
All Filings in PTGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,354 | 60 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $6,324 | 60 | Shares | Sole | 2026-03-31 | |
| 2025-12-31 | $5,240 | 60 | Shares | Sole | 2026-03-02 | |
| No filing history on record for this holder in this stock. | ||||||